Home › Funds › Foresite Capital Management IV, LLC › PHVS

Foresite Capital Management IV, LLC position in PHVS

PHARVARIS N V · Health Care

Foresite Capital Management IV, LLC reported holding 4,778,581 shares of PHVS (PHARVARIS N V) in its Q2 2026 13F filing — a position valued at US$165.2M, representing 56.95% of its reported portfolio and ranking #1 among its reported holdings. Foresite Capital Management IV, LLC has disclosed PHVS holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)4.78M sh
Reported value held$165.24M
Portfolio Weight56.95%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Foresite Capital Management IV, LLC's PHVS position evolved

Foresite Capital Management IV, LLC first disclosed a stake in PHVS in Q3 2023 at 3,743,450 shares (US$78.1M). The position peaked in Q2 2026 at 4,778,581 shares, worth US$165.2M. Across 12 filings, Foresite Capital Management IV, LLC increased the stake 4 time(s), trimmed it 0 time(s) and left it unchanged 7 time(s). The most recent filing (Q2 2026) shows 4,778,581 shares valued at US$165.2M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 3.74M $78.13M New
Q4 2023 4.04M $113.29M Add
Q1 2024 4.04M $93.34M Hold
Q2 2024 4.29M $80.72M Add
Q3 2024 4.40M $81.45M Add
Q4 2024 4.40M $84.31M Hold
Q1 2025 4.41M $69.25M Hold
Q2 2025 4.41M $77.63M Hold
Q3 2025 4.78M $119.23M Add
Q4 2025 4.78M $132.61M Hold
Q1 2026 4.78M $134.99M Hold
Q2 2026 4.78M $165.24M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PHVS and 13F data

PHVS (PHARVARIS N V) is a Health Care company. 49 other funds we track also report a position in PHVS — the largest reported positions include GENERAL ATLANTIC, L.P. (US$226.5M), venBio Partners LLC (US$160.6M), EQT Fund Management S.a r.l. (US$118.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PHVS

All PHVS fund holders →

FAQ

How long has Foresite Capital Management IV, LLC held PHVS?

Foresite Capital Management IV, LLC has disclosed PHVS holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Foresite Capital Management IV, LLC's current position in PHVS?

As of Q2 2026, Foresite Capital Management IV, LLC holds 4.78M shares of PHVS (PHARVARIS N V), valued at $165.24M, representing 56.95% of its reported portfolio and ranking #1.

Has Foresite Capital Management IV, LLC been buying or selling PHVS?

In the latest 13F filing (Q2 2026), Foresite Capital Management IV, LLC held unchanged its position in PHVS. The position peaked in Q2 2026 at 4.78M shares.

Which other funds hold PHVS?

Other major institutional holders of PHVS include GENERAL ATLANTIC, L.P., venBio Partners LLC, EQT Fund Management S.a r.l., among 49 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.